Im YH, Karabulut B, Lee KS, Park BW, et al. Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES. Breast Cancer Res Treat 2021 Mar 16. pii: 10.1007/s10549-021-06173.
PMID: 33728524